The use of pemetrexed in advanced non-small cell lung cancer

被引：0
|
作者：
Ng, C. [1 ]
Harris, M. A. [1 ]
Burt, P. A. [1 ]
Sheikh, H. S. [1 ]
Lee, L. [1 ]
Blackhall, F. H. [1 ]
Summers, Y. [1 ]
Taylor, P. [1 ]
Coote, J. [1 ]
Chittalia, A. [1 ]
Califano, R. [1 ]
Bayman, N. [1 ]
机构：
[1] Christie Hosp NHS Trust, Manchester, Lancs, England
来源：
LUNG CANCER | 2014年 / 83卷
关键词：
D O I：
10.1016/S0169-5002(14)70032-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
31
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of pemetrexed for previously treated advanced non-small cell lung cancer
    Pavlakis, N
    Mitchell, PL
    Slynes, G
    Aristides, M
    Davey, P
    Rajan, N
    Arora, B
    Liepa, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 549S - 549S
  • [32] Pemetrexed-based chemotherapy in advanced nonsquamous non-small cell lung cancer (NSCLC).
    Alshehri, Abdulrahman Ali
    Alsubait, Saud Abdullrhman
    Alamgir, M. Ahsan
    Park, Chandler
    Wen, Sijin
    Luo, Jin
    Ma, Patrick
    Monga, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
    Tucker, Steven
    CURRENT DRUG TARGETS, 2010, 11 (01) : 58 - 60
  • [34] THE BUDGETARY IMPACT OF PEMETREXED MAINTENANCE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Klein, R.
    Lawson, A. H.
    Muehlenbein, C. E.
    Liepa, A. M.
    Wielage, R. C.
    Babineaux, S.
    Koustenis, A. G.
    VALUE IN HEALTH, 2010, 13 (03) : A28 - A28
  • [35] Use review of Erlotinib in advanced non-small cell lung cancer
    Alvarez-Payero, M.
    Ucha-Samartin, M.
    Martinez-Lopez-de-Castro, N.
    Campelo-Sanchez, E.
    Alvarez-Seoane, J.
    Vazquez-Lopez, C.
    Inaraja-Bobo, M. T.
    Perez Parente, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 438 - 438
  • [36] Pseudocellulitis in the Setting of Pemetrexed Treatment for Non-Small Cell Lung Cancer
    Nguyen, Cassidy M.
    Robertson, Jake C.
    Cardenas, Adam
    Martinez, Edgar
    Keeling, Brett H.
    Nguyen, Khang D.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2025, 52 (04) : 284 - 286
  • [37] Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
    Li, Tianhong
    Lara, Primo N., Jr.
    Mack, Philip C.
    Perez-Soler, Roman
    Gandara, David R.
    CURRENT DRUG TARGETS, 2010, 11 (01) : 85 - 94
  • [38] Pemetrexed combination therapy in the treatment of non-small cell lung cancer
    Rosell, R
    Crinó, L
    SEMINARS IN ONCOLOGY, 2002, 29 (02) : 23 - 29
  • [39] Pemetrexed-induced Typhlitis in Non-small Cell Lung Cancer
    Shvartsbeyn, Marianna
    Edelman, Martin J.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (10) : 1188 - 1190
  • [40] Treatment of Non-Small Cell Lung Cancer: Focus on Pemetrexed Disodium
    Feliciano, Josephine
    Patel, Jyoti
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 737 - 748
12345